Tag Archives: Moderna

Study Shows Moderna Vax Effective In Older Adults

Reuters reports: Results from an early safety study of Moderna Inc’s coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots, researchers said on Tuesday. The study, published in the New England Journal of Medicine, offers a more complete …

Read More »

Pharma Says COVID Vax Results Promising For Elderly

Reuters reports: Moderna said on Wednesday its experimental COVID-19 vaccine induced immune responses in older adults similar to those in younger participants, offering hope that it will be effective in people considered to be at high risk for severe complications from the coronavirus. The analysis looked at subjects given the 100-microgram dose being tested in the much larger Phase III …

Read More »

First US Phase Three COVID Vaccine Trial Begins

CNN reports: The first Phase 3 clinical trial of a coronavirus vaccine in the United States began Monday. The investigational vaccine was developed by the biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial is to be conducted at nearly 100 US research sites, according to Moderna. The …

Read More »

Moderna Vax Shows “Promising” Immune Response

The New York Times reports: An experimental coronavirus vaccine made by the biotech company Moderna provoked a promising immune response against the virus and appeared safe in the first 45 people who received it, researchers reported on Tuesday in The New England Journal of Medicine. Moderna’s vaccine, developed with researchers at the National Institute of Allergy and Infectious Diseases, was …

Read More »

NIH Has Ownership Stake In Moderna COVID Vaccine

Axios reports: The National Institutes of Health may own intellectual property that undergirds a leading coronavirus vaccine being developed by Moderna, according to documents obtained by Axios and an analysis from Public Citizen. Because the federal government has an actual stake in this vaccine, it could try to make the vaccine a free or low-cost public good with wide distribution, …

Read More »

Trump’s Vaccine Czar To Divest $10M In Vaccine Stock

The Hill reports: The former drug company executive leading the Trump administration’s coronavirus vaccine initiative said he will divest all his shares in Moderna, one of the initiative’s leading candidates. At the time of his appointment to lead “Operation Warp Speed,” the shares were worth about $10 million. The announcement comes as Moderna’s stock soared almost 20 percent on Monday, …

Read More »

Trump’s Vaccine Czar Has $10M Stake In Vaccine Stock

CNBC reports: Moderna’s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday. Each participant was assigned to receive a 25 microgram, 100 mcg or 250 mcg dose at both vaccinations, with 15 people in each dose group. Study participants received two doses of the potential vaccine via intramuscular …

Read More »